Your browser doesn't support javascript.
loading
Genomic Epidemiology of SARS-CoV-2 in Seychelles, 2020-2021.
Morobe, John Mwita; Pool, Brigitte; Marie, Lina; Didon, Dwayne; Lambisia, Arnold W; Makori, Timothy; Mohammed, Khadija Said; de Laurent, Zaydah R; Ndwiga, Leonard; Mburu, Maureen W; Moraa, Edidah; Murunga, Nickson; Musyoki, Jennifer; Mwacharo, Jedida; Nyamako, Lydia; Riako, Debra; Ephnatus, Pariken; Gambo, Faith; Naimani, Josephine; Namulondo, Joyce; Tembo, Susan Zimba; Ogendi, Edwin; Balde, Thierno; Dratibi, Fred Athanasius; Yahaya, Ali Ahmed; Gumede, Nicksy; Achilla, Rachel A; Borus, Peter K; Wanjohi, Dorcas W; Tessema, Sofonias K; Mwangangi, Joseph; Bejon, Philip; Nokes, David J; Ochola-Oyier, Lynette Isabella; Githinji, George; Biscornet, Leon; Agoti, Charles N.
Afiliação
  • Morobe JM; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Pool B; Seychelles Public Health Laboratory, Public Health Authority, Ministry of Health, Victoria P.O. Box 52, Seychelles.
  • Marie L; Seychelles Public Health Laboratory, Public Health Authority, Ministry of Health, Victoria P.O. Box 52, Seychelles.
  • Didon D; Seychelles Public Health Laboratory, Public Health Authority, Ministry of Health, Victoria P.O. Box 52, Seychelles.
  • Lambisia AW; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Makori T; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Mohammed KS; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • de Laurent ZR; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Ndwiga L; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Mburu MW; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Moraa E; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Murunga N; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Musyoki J; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Mwacharo J; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Nyamako L; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Riako D; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Ephnatus P; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Gambo F; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Naimani J; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Namulondo J; World Health Organization-Seychelles Country Office, Victoria P.O. Box 1217, Seychelles.
  • Tembo SZ; Department of Arbovirology, Emerging and Re-emerging Infectious Diseases-Uganda Virus Research Institution (UVRI), Entebbe P.O. Box 49, Uganda.
  • Ogendi E; World Health Organization-Seychelles Country Office, Victoria P.O. Box 1217, Seychelles.
  • Balde T; World Health Organization-Seychelles Country Office, Victoria P.O. Box 1217, Seychelles.
  • Dratibi FA; World Health Organization Regional Center for Africa, Brazzaville P.O. Box 06, Congo.
  • Yahaya AA; World Health Organization Regional Center for Africa, Brazzaville P.O. Box 06, Congo.
  • Gumede N; World Health Organization Regional Center for Africa, Brazzaville P.O. Box 06, Congo.
  • Achilla RA; World Health Organization Regional Center for Africa, Brazzaville P.O. Box 06, Congo.
  • Borus PK; World Health Organization Regional Center for Africa, Brazzaville P.O. Box 06, Congo.
  • Wanjohi DW; World Health Organization-Kenya Country Office, Gigiri, Nairobi P.O. Box 45335, Kenya.
  • Tessema SK; Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa P.O. Box 3243, Ethiopia.
  • Mwangangi J; Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa P.O. Box 3243, Ethiopia.
  • Bejon P; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Nokes DJ; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Ochola-Oyier LI; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Githinji G; School of Life Sciences and Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Coventry CV4 7AL, UK.
  • Biscornet L; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
  • Agoti CN; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP), Kilifi P.O. Box 230-80108, Kenya.
Viruses ; 14(6)2022 06 16.
Article em En | MEDLINE | ID: mdl-35746789
Seychelles, an archipelago of 155 islands in the Indian Ocean, had confirmed 24,788 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the 31st of December 2021. The first SARS-CoV-2 cases in Seychelles were reported on the 14th of March 2020, but cases remained low until January 2021, when a surge was observed. Here, we investigated the potential drivers of the surge by genomic analysis of 1056 SARS-CoV-2 positive samples collected in Seychelles between 14 March 2020 and 31 December 2021. The Seychelles genomes were classified into 32 Pango lineages, 1042 of which fell within four variants of concern, i.e., Alpha, Beta, Delta and Omicron. Sporadic cases of SARS-CoV-2 detected in Seychelles in 2020 were mainly of lineage B.1 (lineage predominantly observed in Europe) but this lineage was rapidly replaced by Beta variant starting January 2021, and which was also subsequently replaced by the Delta variant in May 2021 that dominated till November 2021 when Omicron cases were identified. Using the ancestral state reconstruction approach, we estimated that at least 78 independent SARS-CoV-2 introduction events occurred in Seychelles during the study period. The majority of viral introductions into Seychelles occurred in 2021, despite substantial COVID-19 restrictions in place during this period. We conclude that the surge of SARS-CoV-2 cases in Seychelles in January 2021 was primarily due to the introduction of more transmissible SARS-CoV-2 variants into the islands.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Screening_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article